Thus, Minamino et al. demonstrated that in adipose tissue p53 expression as a biomarker of senescence is crucially involved in the development of insulin resistance, which underlies age-related cardiovascular and metabolic disorders (Minamino et al., 2009). This evidence concerns the gene TP53 and metabolic disease.